Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AEON BIOTECH AS
AS
Active
Org 932248174
Pareliusveien 13F, 1177 Oslo
General medical practice activities · NACE 8621
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 113K
+451% vs 2023
EBITDA margin
-183.1%
+69% vs 2023
Equity ratio
-362.1%
Financial strength
Net profit 2024
NOK -207K
+69% vs 2023
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
-1M
2023
0M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 113K
+451%
EBITDA
NOK -207K
+69%
Net profit
NOK -207K
+69%
Total assets
NOK 36K
-59%
Equity
NOK -131K
-273%
Employees
0
—
Company information
Legal name
AEON BIOTECH AS
Org number
932248174
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
7. november 2023
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Formidle og utvikle helsefremmende og helseforebyggende teknologi og produkter.
Contact
Address
Pareliusveien 13F, 1177 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
-1M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
21
113
Staff expenses
−0
−0
EBITDA
−669
−207
Depreciation & amort.
−0
−0
EBIT
−669
−207
Net financials
0
−0
Profit before tax
−669
−207
Tax
−0
−0
Net profit
−669
−207
Balance sheet
NOK thousands
Item
2023
2024
Total assets
88
36
Equity
76
−131
Long-term debt
0
60
Short-term debt
12
108
Total debt
12
168
Financial ratios
5-year trend
EBITDA margin
-183.1%
This company
15.8%
Market median
-1259% vs market
2023
2024
Equity ratio
-362.1%
This company
38.2%
Market median
-1048% vs market
2023
2024
Return on equity
-20719900.0%
This company
18.4%
Market median
-112608252% vs market
2023
2024
Net profit margin
-183.3%
This company
8.1%
Market median
-2363% vs market
2023
2024
Asset turnover
3.11×
This company
1.12×
Market median
+178% vs market
2023
2024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-10-16 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JO
Jan Olav Frederic Rivelsrud
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
JK
Jon Kåre Stene
Board of Directors
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Rivelsrud As
Company
80.0%
80.0%
2024
Skyfall Ventures Fund I As
Company
10.0%
10.0%
2024
Age Labs As
Company
10.0%
10.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Rivelsrud As
AEON BIOTECH AS
(this company)
Board network connections
Board members of AEON BIOTECH AS also hold positions in
0
other companies.
Person
Role here
Other companies
Jan Olav Frederic Rivelsrud
Chief Executive Officer
0 companies
Jon Kåre Stene
Board of Directors
0 companies